News Breaks |
|
|
| January 7, 2013 |
| 08:35 EDT |  | THOR | Thoratec announces FDA approval to commence REVIVE-IT study
Thoratec announced that the FDA has granted an Investigational Device Exemption to commence the REVIVE-IT study utilizing the HeartMate II Left Ventricular Assist System. REVIVE-IT is a prospective, randomized, controlled trial designed to compare the use of the HeartMate II LVAD with optimal medical management in patients with New York Heart Association (NYHA) Class III heart failure. This feasibility study is intended to provide initial scientific evidence regarding the potential advantages of MCS therapy in treating earlier-stage, less ill heart failure patients who are currently not indicated for LVAD support. |
|
|
News For THOR From The Last 14 Days Check below for free stories on THOR the last two weeks. |
|
|
| May 20, 2013 |
| 10:11 EDT |  | THOR | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Artisan Partners (APAM) downgraded to Market Perform from Outperform at Keefe Bruyette... Bank of America (BAC) downgraded to Market Perform from Outperform at Keefe Bruyette... Bed Bath & Beyond (BBBY) downgraded to Hold from Buy at Jefferies... BlackRock (BLK) downgraded to Market Perform from Outperform at Keefe Bruyette... Cavium (CAVM) downgraded to Market Perform from Outperform at JMP Securities... Charles Schwab (SCHW) downgraded to Underperform from Market Perform at Keefe Bruyette... Dunkin' Brands (DNKN) downgraded to Neutral from Buy at Longbow... Equifax (EFX) downgraded to Neutral from Buy at Goldman... Leap Wireless (LEAP) downgraded to Sell from Hold at Deutsche Bank... Lowe's (LOW) downgraded to Perform from Outperform at Oppenheimer... MicroStrategy (MSTR) downgraded to Market Perform from Outperform at JMP Securities... NetApp (NTAP) downgraded to Underperform from Neutral at RW Baird... NeuStar (NSR) downgraded to Neutral from Buy at Goldman... Red Hat (RHT) downgraded to Market Perform from Outperform at BMO Capital... Ruby Tuesday (RT) downgraded to Market Perform from Outperform at Wells Fargo... Synovus (SNV) downgraded to Sell from Neutral at Goldman... TD Ameritrade (AMTD) downgraded to Underperform from Market Perform at Keefe Bruyette... Thoratec (THOR) downgraded to Neutral from Buy at Goldman... CF Industries (CF) downgraded to Hold from Buy at Miller Tabak... Children's Place (PLCE) downgraded at Susquehanna... CarMax (KMX) downgraded to Market Perform from Outperform at William Blair... SanDisk (SNDK) downgraded to Neutral from Buy at Nomura... Red Hat (RHT) downgraded at BMO Capital... Rex Energy (REXX) downgraded to Hold from Buy at Stifel... Range Resources (RRC) downgraded to Hold from Buy at Stifel... Kansas City Southern (KSU) downgraded to Sell from Hold at Stifel... Capella Education (CPLA) downgraded to Hold from Buy at Stifel. |
|
| 06:06 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Goldman
 Subscribe for More Information |
|
| May 17, 2013 |
| 08:04 EDT | | THOR | Thoratec announces FDA approval of HeartMate II Pocket Controller
Thoratec announced that it has received approval from the FDA to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System. |
|
| May 13, 2013 |
| 10:09 EDT | | THOR | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 07:31 EDT | | THOR | Thoratec downgraded to Neutral from Buy at Lazard Capital
Subscribe for More Information |
|
|
|
|
|
